Search
Assembling a Scientific Package for Better Commercial Outcomes
Our commercial arm, Drug Development, Inc. (DDI), acts as an interface between the Centre for Drug Research and Development and industry. The company in-licenses intellectual property generated from selected CDRD projects directly from affiliated institutions’ technology transfer offices or inventors. We fund and advance programs through preclinical development, with the goal of developing robust and complete technology dossiers to support successful commercialization.
Licensing
We also consider technologies for in-licensing as well as opportunities for strategic partnerships with pharmaceutical and biotech companies to attract funding and advance promising technologies through development. Programs will eventually be out-licensed to pharmaceutical or biotech partners or spun off as life sciences companies. Profits from Drug Development, Inc. flow back to CDRD to continue to support ongoing drug-development projects, operations, facility improvements, and equipment renewals. DDI will help CDRD become self-sustaining.